archive
REX·DAILY
Friday July 24 Anno 2026 · Ibaraki, Osaka
I Daily Wisdom
Robert Greene The Daily Laws July 24 · Make Them Fetishize You

When Marlene Dietrich entered a room, or arrived at a party, all eyes inevitably turned to her. First there were her startling clothes, chosen to make heads turn. Then there was her air of nonchalant indifference. Men, and women too, became obsessed with her, fetishizing her long after other memories of the evening had faded. She had a distance from her own self: she could study her face, her legs, her body, as if she were someone else. This gave her the ability to mold her look, transforming her appearance for effect. She was like a beautiful object, something to fetishize and admire the way we admire a work of art. If you see yourself as an object, then others will too. An ethereal, dreamlike air will heighten the effect. Consider yourself a blank screen. Float through life noncommittally and people will want to seize you and consume you. Of all the parts of your body that draw this fetishistic attention, the strongest is the face; so learn to tune your face like an instrument, making it radiate a fascinating vagueness for effect. And since you will have to stand out from other Stars in the sky, you will need to develop an attention-getting style. Dietrich was the great practitioner of this art; her style was chic enough to dazzle, weird enough to enthrall.

Daily Law: Your own image and presence are materials you can control. The sense that you are engaged in this kind of play will make people see you as superior and worthy of imitation.

The Art of Seduction

: The Star

Steven Pressfield The Daily Pressfield Day 205

THE MORE EXCRUCIATING THE HERO’S JOURNEY, THE BETTER What we don’t want at this stage of our evolution/story is the Hero’s Journey Lite. We want the adult portion. We want the full catastrophe. Why? Because the full catastrophe sticks. The full catastrophe tattoos itself on our brain (and our hero’s) so we never forget. Unpublished Black Irish JAB, “The Hero’s Journey” Rule of thumb for fiction writers: The more agony you can put your protagonist through, the more the audience will love it. Not because we as readers are rooting against our hero. We’re not. We’re rooting for him. We just know in our guts that the more we suffer (or the more our fictional heroes do), the deeper the lessons will sink in and the better we (and they) will be in the end. One proviso of course: We have to survive the journey.

Leo Tolstoy A Calendar of Wisdom July 24

When one understands life’s law, one manifests the part of God which lives inside him.

Every man, from the king to the poorest pauper, should seek his own perfection, because only self-perfection improves mankind.

—CONFUCIUS

In the long run, people achieve only that which they have set as goals for themselves; therefore, set the highest possible goals for yourself.

The fulfillment of the law of goodness has nothing in common with everyday material prosperity.

Sometimes material prosperity and moral goodness clash in conflict.

These sufferings lead to the highest elevation of spirit.

II The Day Ahead
  • Tomorrow · 09:30 Google account handoff with Mark ewijaya@gmail.com
  • Tomorrow · 10:30 サークル(土) 2026年間予定
III Signals & Dispatches

AI / ML

  • @emollicksource ↗ Ethan Mollick updated his practical guide to which AI systems non experts should use now, stressing that consumer agentic tools are powerful but confusing.
  • @kimmonismussource ↗ Kimmonismus flags a claimed Codex run that drafted approaches to six Erdős problems through autonomous proof attempts, adversarial audits, and repairs.
  • @gregisenbergsource ↗ Greg Isenberg predicts agent management becomes a mainstream work skill, from hiring agents to paying for human support as a premium tier.

Drug Discovery

  • @RaphaelNithinsource ↗ Reuters coverage of Insilico Medicine says AI plus China R&D compressed candidate discovery from about four and a half years to roughly thirteen months, with no approved drugs yet.
  • @Nymnesource ↗ Nymne notes one major AI company is treating broad biology support as uniquely risky while others continue serving bio researchers, a policy split worth watching.

Biotech

  • @BioTech_Awardssource ↗ GEN coverage spotlights efforts to standardize personalized CRISPR gene editing therapies, a useful signal for where regulatory and manufacturing bottlenecks are moving.
  • @jibun_no_tweetssource ↗ A Japanese biotech law thread argues EFPIA supports clearer rules for clinical trial and research participant data where GDPR created operational ambiguity.
  • @ManpreetBolasource ↗ Manpreet Bola links contagious cancer, AI designed CRISPR enzymes, and longevity work under one thesis: biology is becoming an engineering discipline.

Tech

  • @UnitreeRoboticssource ↗ Unitree showed an omni modal whole body mobile manipulation model aimed at stable autonomous home care and wellness tasks.
  • @ai_news_24hsource ↗ A tech digest says OpenAI and Broadcom are pursuing ten gigawatts of custom AI accelerators while Brookfield and Bloom target independent power for data centers.
  • @financialjuicesource ↗ Nvidia and KAIST opened a joint AI research lab in Korea, another sign that national AI capacity is clustering around hardware partnerships.

Japanese Politics

  • @NatsukiYasudasource ↗ Natsuki Yasuda revisits blurred boundaries between politics and the Self Defense Forces after a uniformed SDF singer appeared at an LDP convention.
  • @ryusei_kawakamisource ↗ Ryusei Kawakami supports backup capital functions in principle but criticizes Osaka centric deputy capital planning as too fragile for simultaneous wide area disasters.
  • @hmatsu63source ↗ A Digital Agency update highlights local government digital reform ambassadors and an LDP proposal on digital administrative reform.
IV Sky over Ibaraki
⛅ +30°C
humidity 62% · wind 6 km/h NNE
warm and partly cloudy; carry water rather than an umbrella
V What Rex Can Do Today
  1. Check the Fr. Conor Google handoff plan before the Saturday call with Mark and prepare a clean fallback message if approval is needed.
  2. Review the LinkedIn and X reply queues for AI drug discovery conversations Boss can safely enter today.
  3. Tidy one memory or project note from this week so the recurring automations have cleaner context.
VI Toward the Long Game
  1. Read one recent review or preprint on generative molecular design with explicit attention to experimental validation, not just benchmark curves.
  2. Spend thirty minutes mapping Boss’s TRIM peptide work into an AI drug discovery leadership story for interviews and LinkedIn.
  3. Identify one Kansai or Singapore AI biotech contact to reconnect with, preferably someone working on translational data or peptide therapeutics.